Abstract
Cytotoxic T-lymphocytes (CTLs) kill abnormal cells. CTLs recognize major histocompatibility complex class I molecules in complex with peptides derived from relevant antigens. The identification of tumor associated antigen peptides enabled the design of anti-tumor and anti-metastatic vaccines in a murine lung carcinoma.
| Original language | English |
|---|---|
| Pages (from-to) | 323-328 |
| Number of pages | 6 |
| Journal | International Journal of Peptide Research and Therapeutics |
| Volume | 5 |
| Issue number | 5-6 |
| DOIs | |
| State | Published - 1998 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Immunotherapy
- MHC class I
- Tumor metastases
Fingerprint
Dive into the research topics of 'Tumor-associated antigen peptides as anti-metastatic vaccines'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver